Drug-Drug Interaction Study: ASP2151 and Montelukast

NCT02321748 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Montelukast
DRUG: ASP2151

Sponsor

Maruho Europe Limited